June 22, 2020 / 11:30 AM / 20 days ago

BRIEF-Esperion And Daiichi Sankyo Europe Announce Amendment To License And Commercial Collaboration Agreement

Daiichi Sankyo Co Ltd:

* ESPERION AND DAIICHI SANKYO EUROPE ANNOUNCE AMENDMENT TO LICENSE AND COMMERCIAL COLLABORATION AGREEMENT

* ESPERION THERAPEUTICS - DAIICHI SANKYO EUROPE WILL NOW PAY CO SECOND $150 MILLION MILESTONE BASED ON COMPLETION OF MAA TRANSFER

* ESPERION THERAPEUTICS - ELIGIBLE TO RECEIVE UP TO $900 MILLION IN TOTAL MILESTONES AS WELL AS TIERED ROYALTIES BETWEEN 15% - 25% Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below